World / Cardiology
Rivaroxaban Phase II Dose-Ranging Study Demonstrates Encouraging Response Rates In Treatment Of Acute Coronary Syndrome Patients
12.11.2008 12:17
medicalnewstoday.com
Findings from the Phase II ATLAS ACS TIMI 46 study of rivaroxaban, a novel, investigational, oral anticoagulant, were presented today as a late-breaking clinical trial at the American Heart Association's Scientific Sessions 2008 in New Orleans by C. Michael Gibson, M.D., director of the TIMI Data Coordinating Center, Harvard Medical School.
World
Cardiology
FDA Approves Boston Scientific's Apex™ PTCA Dilatation Catheter
12.11.2008 12:17
medicalnewstoday.com
Boston Scientific Corporation (NYSE: BSX) today announced that it has received approval from the U.S. Food and Drug Administration to market its Apex™ PTCA(1) Dilatation Catheter. The Apex Catheter is a high-performance pre-dilatation balloon catheter developed specifically to address physicians' needs in treating the most challenging atherosclerotic lesions. It is available for distribution in both Monorail® and Over-The-Wire (OTW) catheter platforms.
World
Cardiology
Loyola Study Finds Catheter Ablation Superior To Medication For Atrial Fibrillation
12.11.2008 12:17
medicalnewstoday.com
Treating a common heart rhythm disorder by burning heart tissue with a catheter works dramatically better than drug treatments, a major international study has found. One year after undergoing a treatment called catheter ablation, 75 percent of patients with an irregular heartbeat called atrial fibrillation were free of symptoms. By comparison, only 21 percent of those treated with drugs were symptom-free. Results were so convincing the trial was halted early.
World
Cardiology
Preventing Anemia Is Important To Kidney Disease Patients' Quality Of Life
12.11.2008 12:17
medicalnewstoday.com
Maintaining sufficient red blood cell levels is important to the physical and mental health of patients with chronic kidney disease (CKD), according to a study appearing in the January 2009 issue of the Clinical Journal of the American Society Nephrology (CJASN). The findings indicate that preventing anemia in kidney disease patients should be an integral part of their care.
World
Cardiology
Endocrine Society Releases Clinical Guideline On Metabolic Syndrome
12.11.2008 12:17
medicalnewstoday.com
The Endocrine Society has released a new clinical practice guideline for the primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk. The guideline appears in the October issue of the Journal of Clinical Endocrinology & Metabolism (JCEM), a publication of The Endocrine Society. There is growing evidence that many patients who develop cardiovascular disease or diabetes have a pre-existing metabolic risk.
World
Cardiology
Study Might Prompt Expanded Use Of Crestor, Increase U.S. Health Care Costs By $10B Annually, Analysis Finds
12.11.2008 08:17
medicalnewstoday.com
Use of the cholesterol medication Crestor, manufactured by AstraZeneca, to prevent cardiovascular events in patients who do not have high cholesterol levels but have high levels of C-reactive protein would increase U.S. health care costs by $10 billion annually, according to an analysis released on Monday,
World
Cardiology
Health Risks For Large, Retired Athletes May Be Lowered By Staying Active
12.11.2008 08:17
medicalnewstoday.com
Study highlights: Retired NFL players have fewer heart disease risk factors overall, but higher cholesterol and glucose levels. Physical activity may have prevented the development of higher rates of diabetes or greater amounts of atherosclerosis. Since today's players are 50 percent larger than 25 years ago, further study is needed on whether current players are at greater risk for cardiovascular events or death, researchers said.
World
Cardiology
Comparison Of Cell-Coated And Drug-Coated Stents
12.11.2008 08:17
medicalnewstoday.com
Study highlights: A stent that coats itself with the cells that line blood vessels is as effective as a drug-coated stent in preventing artery reblockage and blood clots for people with coronary artery disease. Unlike drug-eluting stents, the new device requires only short-term antiplatelet therapy. This stent is in use in many countries, but the Food and Drug Administration has not yet approved it for marketing in the United States.
World
Cardiology
Artery Plaque In Obese Kids' Similar To Middle-Aged Adults
12.11.2008 08:17
medicalnewstoday.com
Study highlights: The plaque buildup in the neck arteries of obese children or those with high cholesterol is similar to levels in middle-aged adults. Using ultrasound images, researchers equated the "vascular age" to be 45 years old in these children.
World
Cardiology
Higher Death Rates In Minority Children Waiting For Heart Transplants
12.11.2008 08:17
medicalnewstoday.com
Study highlights: Minority children on the waitlist for a heart transplant have a greater risk of dying than white children do. Socioeconomic factors explain only a small fraction of this increased risk. When all factors including race, area income and insurance were simultaneously considered, children with Medicaid insurance were 20 percent more likely to die while awaiting transplant.
World
Cardiology
Cardio & Vascular Coalition Needs Your Experience
12.11.2008 06:17
medicalnewstoday.com
The Cardio & Vascular Coalition (CVC) is a collaboration of voluntary and professional organisations working for improved cardio and vascular health. Diabetes UK is a member of the CVC, whose interests span all heart and circulatory diseases (including heart disease and stroke), as well as the related conditions of kidney disease and diabetes. These conditions share many risk factors, so the CVC is campaigning for a Cardio & Vascular Health Strategy for 2010 - 2020.
World
Cardiology
Heart Failure Hospitalization Rates Rise Among Nation's Seniors
12.11.2008 06:17
medicalnewstoday.com
Heart failure is reaching epidemic levels among seniors in the United States, according to research presented at the American Heart Association's Scientific Sessions 2008. "Both the number of patients hospitalized with a primary diagnosis of heart failure and age-adjusted hospitalization rates for heart failure have increased dramatically over the past 27 years," said Longjian Liu, M.D., Ph.D., M.Sc.
World
Cardiology
Risk Of Blood Clots Forming In Veins May Be Reduced By Flu Shots
12.11.2008 06:17
medicalnewstoday.com
Flu shots may reduce the risk of blood clots forming in veins by 26 percent, according to research presented at the American Heart Association's Scientific Sessions 2008. "Our study suggests for the first time that vaccination against influenza may reduce the risk of venous thrombotic embolism (VTE)," said Joseph Emmerich, M.D., Ph.D.
World
Cardiology
Prevention Of Coronary Heart Disease: New Findings On The Role Of Inflammation
12.11.2008 06:17
medicalnewstoday.com
This year, about 450,000 Americans will die of coronary heart disease - the leading cause of death for both men and women. Although we have made great strides in preventing and treating heart disease, we continue to explore the complex mechanisms involved in cardiovascular disease, and we are eager to refine risk assessment tools and preventive strategies to reduce the incidence of heart attack and stroke.
World
Cardiology
Long-term Data For Pradaxa(R) (dabigatran Etexilate) For Stroke Prevention In Atrial Fibrillation (AF)
12.11.2008 06:17
medicalnewstoday.com
Long-term data for Pradaxa® (dabigatran etexilate) in the prevention of thromboembolic events in patients with recurrent, persistent and chronic AF was presented today at the 80th American Heart Association annual congress.
World
Cardiology
English